A Senate committee on Monday advanced legislation that would overhaul how New Jersey develops and implements its immunization standards, aiming to bring greater consistency to vaccine policy across state agencies while reinforcing reliance on evidence-based medical guidance.
The bill, S-4894/4726, sponsored by Sen. Joe Vitale (D-Middlesex), would update statutory and regulatory references so that the New Jersey Department of Health becomes the state’s primary authority for issuing immunization recommendations. In crafting and revising those standards, the Department would be required to consider guidance from the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention, as well as leading medical organizations including the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, and the American College of Physicians.
Under the proposal, all state agencies would be required to align their regulations with Department of Health immunization recommendations, creating a uniform statewide framework for vaccine requirements.
“New Jersey families and health care providers rely on consistent, evidence-based vaccine guidance,” Vitale said. He noted that recent federal actions — including the move to scale back longstanding recommendations for the Hepatitis B birth dose — illustrate how quickly national policy can shift. “New Jersey should not be dependent on abrupt changes that could undermine confidence in immunizations. By empowering the Department of Health to consider the full spectrum of expert recommendations, we are building a more resilient and dependable vaccine policy for our State.”
The bill also includes a significant insurance component: health insurers and the State Medicaid Program would be required to cover recommended immunizations without cost-sharing when the Department of Health endorses them. Coverage decisions would similarly be informed by ACIP guidance and the recommendations of major medical organizations listed in the legislation.
New Jersey would join a growing number of states — including California, Colorado, Maine, Maryland, and Washington, D.C. — that have moved toward independent or supplemental vaccine guidance in response to evolving federal policy. More than twenty states now rely on nonfederal entities for some portion of their immunization decision-making.
The bill now heads to the full Senate for further consideration.